Skip to main content
Melissa Delbello, MD, Psychiatry, Cincinnati, OH, University of Cincinnati Medical Center

MelissaDelbelloMD

Psychiatry Cincinnati, OH

Child & Adolescent Psychiatry

Professor, Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine

Dr. Delbello is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Delbello's full profile

Already have an account?

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Child and Adolescent Psychiatry, 1998 - 2000
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Psychiatry, 1995 - 1999
  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Psychiatry, 1995 - 1998
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1995

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1996 - 2025
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Discrete Patterns of Cortical Thickness in Youth with Bipolar Disorder Differentially Predict Treatment Response to Quetiapine but Not Lithium  
    Melissa P DelBello, Caleb M Adler, Jeffrey R Strawn, Fabiano G Nery, Nature

Authored Content

  • Clinical Relevance Versus Statistical Significance: DelBello and Colleagues Respond to EditorialApril 2018
  • Efficacy and Safety of Lurasidone in Children and Adolescents with Bipolar I Depression: A Double-Blind, Placebo-Controlled StudyOctober 2017
  • Efficacy and Safety of Lurasidone in Children and Adolescents with Bipolar I Depression: A Double-Blind, Placebo-Controlled StudyOctober 2017

Press Mentions

  • Comorbid Substance Use Disorders Among Youth with Bipolar Disorder: Opportunities for Early Identification and Prevention
    Comorbid Substance Use Disorders Among Youth with Bipolar Disorder: Opportunities for Early Identification and PreventionAugust 18th, 2009

Grant Support

  • Multimodal Neuroimaging Of Treatment Effects In Adolescent ManiaNational Institute Of Mental Health2009–2012
  • Neurochemical Effects Of Omega-3 Fatty Acids In Adolescents At Risk For ManiaNational Institute Of Mental Health2009–2011
  • Topiramate For Co-Occurring Alcohol Use And Bipolar Disorders In AdolescentsNational Institute On Alcohol Abuse And Alcoholism2008–2009
  • Topiramate For Co-Occurring Cannabis Use And Bipolar Disorders In AdolescentsNational Institute On Drug Abuse2006–2008
  • Brain Abnormalities In Adolescent Bipolar DisorderNational Institute Of Mental Health2002–2006

Hospital Affiliations